The estimated Net Worth of Ronald M. Lombardi is at least $28.5 Milion dollars as of 8 August 2023. Mr. Lombardi owns over 32,800 units of Prestige Consumer Healthcare Inc stock worth over $21,574,750 and over the last 14 years he sold PBH stock worth over $1,858,929. In addition, he makes $5,051,680 as Chairman of the Board, President a Chief Executive Officer at Prestige Consumer Healthcare Inc.
Sign up
Mr. Lombardi PBH stock SEC Form 4 insiders trading
Ronald has made over 16 trades of the Prestige Consumer Healthcare Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 32,800 units of PBH stock worth $1,098,800 on 8 August 2023.
The largest trade he's ever made was buying 60,000 units of Prestige Consumer Healthcare Inc stock on 17 February 2022 worth over $531,000. On average, Ronald trades about 4,464 units every 49 days since 2010. As of 8 August 2023 he still owns at least 303,357 units of Prestige Consumer Healthcare Inc stock.
You can see the complete history of Mr. Lombardi stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Ronald Lombardi biography
Ronald M. Lombardi is a Chairman of the Board, President, Chief Executive Officer of Prestige Brands Holdings, Inc. Mr. Lombardi currently serves on the board of ACCO Brands Corporation. He served as Chief Financial Officer of the Company from December 2010 until November 2015. Prior to joining the Company, from October 2010 to December 2010, Mr. Lombardi was employed by Medtech Group Holdings, a components and contract medical device manufacturer, as Chief Financial Officer. From October 2009 to October 2010, Mr. Lombardi served as the Chief Financial Officer of Waterbury International Holdings, a specialty chemical and pest control business. Mr. Lombardi was employed by Cannondale Sports Group, a sporting goods and apparel manufacturing company, as Chief Operating Officer from August 2008 to October 2009 and as Senior Vice President and Chief Financial Officer from March 2004 to August 2008. From 2000 to 2004, Mr. Lombardi served in various roles at Gerber Scientific Inc., including Vice President and Chief Financial Officer of Gerber Scientific Inc.’s Gerber Coburn Optical Division and Director of Financial Planning and Analysis of Gerber Scientific Inc. Mr. Lombardi was also previously employed by Emerson Electric, Scovill Fasteners, Inc. and Go/Dan Industries. Mr. Lombardi received a B.S. from Springfield College and an M.B.A. from American International College and has been a licensed CPA.
What is the salary of Ronald Lombardi?
As the Chairman of the Board, President a Chief Executive Officer of Prestige Consumer Healthcare Inc, the total compensation of Ronald Lombardi at Prestige Consumer Healthcare Inc is $5,051,680. There are no executives at Prestige Consumer Healthcare Inc getting paid more.
How old is Ronald Lombardi?
Ronald Lombardi is 56, he's been the Chairman of the Board, President a Chief Executive Officer of Prestige Consumer Healthcare Inc since 2017. There are 9 older and 5 younger executives at Prestige Consumer Healthcare Inc. The oldest executive at Prestige Consumer Healthcare Inc is James Jenness, 73, who is the Independent Director.
What's Ronald Lombardi's mailing address?
Ronald's mailing address filed with the SEC is C/O ACCO BRANDS CORPORATION, , LAKE ZURICH, IL, 60047.
Insiders trading at Prestige Consumer Healthcare Inc
Over the last 20 years, insiders at Prestige Consumer Healthcare Inc have traded over $32,224,266 worth of Prestige Consumer Healthcare Inc stock and bought 60,410 units worth $1,162,754 . The most active insiders traders include Matthew Mannelly, James M Jenness a Dawn M. Zier. On average, Prestige Consumer Healthcare Inc executives and independent directors trade stock every 62 days with the average trade being worth of $2,469,571. The most recent stock trade was executed by Mary Beth Fritz on 1 March 2024, trading 172 units of PBH stock currently worth $6,908.
What does Prestige Consumer Healthcare Inc do?
at prestige brands, now prestige consumer healthcare, we focus on product innovation and quality in over-the-counter healthcare products to improve the lives of our customers worldwide. you may not know who prestige consumer healthcare is, but you know and use our products: clear eyes, dentek, summer's eve, monistat, bc, goody's, dramamine, and many more. for generations, our trusted brands have helped consumers care for themselves and their loved ones. our mission is to preserve this trust by continuing to provide products stewarded with our customer needs in mind. prestige consumer healthcare is a different kind of company. we are the largest independent provider of over-the-counter healthcare products in north america yet we are nimble enough to give detailed attention to each and every one of our product offerings. we are constantly improving, creating products that match the ever-changing lifestyles and needs of people and families everywhere. prestige’s success as a company is th
What does Prestige Consumer Healthcare Inc's logo look like?
Complete history of Mr. Lombardi stock trades at Acco Brands a Prestige Consumer Healthcare Inc
Prestige Consumer Healthcare Inc executives and stock owners
Prestige Consumer Healthcare Inc executives and other stock owners filed with the SEC include:
-
Ronald Lombardi,
Chairman of the Board, President, Chief Executive Officer -
Ronald M. Lombardi,
Chairman, Pres & CEO -
Christine Sacco,
Chief Financial Officer -
William PPool,
Senior Vice President, General Counsel and Corporate Secretary -
Adel Mekhail,
Executive Vice President - Sales and Marketing -
Christine Sacco,
Chief Financial Officer -
Jeffrey Zerillo,
Senior Vice President, Operations -
Adel Mekhail,
Exec. VP of Marketing & Sales -
William C. P'Pool,
Sr. VP, Gen. Counsel & Corp. Sec. -
Jeffrey Zerillo,
Sr. VP of Operations -
Gary Costley,
Lead Independent Director -
John Byom,
Independent Director -
James Jenness,
Independent Director -
Natale Ricciardi,
Independent Director -
Sheila Hopkins,
Independent Director -
Christopher Coughlin,
Independent Director -
Dawn Zier,
Independent Director -
Mary Beth Fritz,
Sr. VP of Quality & Regulatory Affairs -
Dean Siegal,
Director of Communications -
Philip David Terpolilli,
Director of Investor Relations -
John F. Kelly,
Director -
Lieven Nuyttens,
Senior VP, Operations -
Partners Viii L Pgtcr Golde...,
-
Paul Migaki,
VP Strategic Planning/Canada -
Thomas Hochuli,
Vice President, Operations -
David S Marberger,
Chief Financial Officer -
Timothy Connors,
Chief Marketing Officer -
John Parkinson,
Senior VP- International -
Christopher Heye,
See remarks -
Carl J Johnson,
Director -
Samuel C Cowley,
General Counsel, VP Bus. Dev. -
James E Kelly,
Senior VP - Marketing -
Mark Pettie,
Chairman of the Board and CEO -
Ronald B Gordon,
Director -
Charles Schrank,
Senior V.P. of Marketing -
Peter Anderson,
Chief Financial Officer -
David Talbert,
Senior Vice President, Sales -
Gerard Butler,
Chief Sales Officer -
Co Invest Ii Lpgtcr Golder ...,
-
Fund Viii Lpgtcr Partners V...,
-
Jean A Boyko,
SVP, Quality & Reg. Affairs -
John Byom,
Director -
Eric S. Klee,
Secretary and General Counsel -
Peter Mann,
Chief Executive Officer -
L Dick Buell,
Director -
Mezzanine Partners Lpgtcr P...,
-
Frank Palantoni,
President and COO -
Eric Millar,
Senior V.P. of Operations -
Charles Hinkaty,
Director -
Matthew Mannelly,
President and CEO -
Michael Fink,
Senior V.P. of Marketing -
Raymond Silcock,
Director -
Paul A. Hennessey,
Vice President, Operations -
Patrick Lonergan,
Director -
Vincent J Hemmer,
Director -
Mezzanine Partners Lpgtcr G...,
-
Fund Viii/B L Pgtcr Partner...,
-
Golder Rauner Ii Llc Gtcr,
10% owner -
Capital Partners L Pgtcr Me...,
-
David Donnini,
Director -
Charles Jolly,
Secretary & General Counsel -
Celeste A. Clark,
Director -
James D Arecca,
Director -
William P'pool,
See Remarks -
Mary Beth Fritz,
SVP Quality & Regulatory